ArticleJournal of medical systems2026
Development and Exploratory Evaluation of a Large Language Model-Supported Scoping Review Workflow.
Article in Journal of medical systems, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Large language models (LLMs) have demonstrated human-level performance in literature review screening phases and have been evaluated in systematic-review workflows. However, LLM performance in scoping reviews, which are broader and more heterogeneous, remains understudied. We developed a modular LLM-supported framework for scoping-review workflows and compared the performance of two general-purpose LLMs against human reviewers on a reference scoping review. The reference review's keyword search results (n = 1336) and prompt sets mirroring workflow stages were provided to GPT-5 and gpt-oss-20b (OpenAI, August 2025). Outputs were benchmarked against human decisions for agreement; disagreements were adjudicated. For title-abstract screening and final-inclusion concordance, unanimous and adjudicated decisions were combined into a composite reference standard. In title-abstract screening, GPT-5 and gpt-oss-20b workflows showed substantial interrater agreement with human consensus (AC1: 0.769; 0.722); reference concordance was 90.9% (p = 0.08) and 92.4% (p = 0.004) versus humans' 89.0%. For final inclusion status, interrater agreement was almost-perfect (AC1: 0.948; 0.853); reference concordance was 95.4% (p = 0.23) and 92.4% (p < 0.001) versus humans' 96.1%. Across data categorization/synthesis, interrater agreement was fair to almost-perfect (AC1: 0.493-0.949; 0.342-0.929); total variation distances (representing distribution divergence) were 1.55%-28.0%. All sources found comparably low definition-adherent use rates of the term "human digital twin" (humans 12.1%; GPT-5 13.0%; gpt-oss-20b 18.0%). Both LLM-supported workflows achieved fair to almost-perfect agreement and high screening/final-inclusion reference concordance. The main synthesis finding was directionally consistent across workflows, with all sources identifying infrequent correct use of "human digital twin"; total variation distance may be useful in assessing distribution-level concordance. Limitations include a single domain/vendor, fixed prompts, and predefined taxonomies; broader evaluations are warranted. In this single-domain benchmark, LLM-supported scoping-review workflows showed feasibility for supporting and potentially streamlining selected review stages, with broadly comparable performance on evaluated endpoints and conclusion-level concordance. Generalizability, reproducibility, and operational efficiency beyond this benchmark remain to be established.
Indexed as
Identifiers
42878908What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.